Global Cancer Statistics 2024: GLOBOCAN Estimates of Incidence and Mortality Worldwide Researchers from the International Agency for Research on Cancer (IARC) and the American Cancer Society (ACS) have released updated global cancer statistics for 2024, revealing that approximately 20.6 million people were diagnosed with cancer worldwide, while 9.8 million deaths were attributed to the disease. These figures, part of the GLOBOCAN project, cover 34 cancer types across 186 countries and underscore the significant global health burden of cancer. The data highlight that one in five individuals will develop cancer during their lifetime, with one in nine men and one in 13 women expected to die from the disease. Lung cancer remains the most frequently diagnosed cancer, accounting for 12.8% of all new cases, followed by female breast cancer (11.8%), colorectal cancer (9.9%), prostate cancer (7.5%), and stomach cancer (4.8%). Lung cancer also leads in mortality, responsible for 19.1% of all cancer-related deaths, with colorectal cancer (9.4%), liver cancer (7.5%), female breast cancer (7.1%), and stomach cancer (6.6%) following closely. The estimates emphasize the disproportionate impact of these cancers, particularly in regions with limited access to early detection and treatment. Of the 20.6 million new cancer cases recorded in 2024, 19.5 million were classified as non-skin cancers, while 9.7 million deaths were attributed to non-skin cancer types. The report also includes projections for the future, predicting that cancer incidence will rise to 34.4 million cases by 2050—a 67% increase compared to 2024.#world_health_organization #american_cancer_society #international_agency_for_research_on_cancer #globo_can #ca_a_cancer_journal_for_clinicians
